MetricSide LogoMetricSide
Learn
  1. Home
  2. Companies
  3. Healthcare
  4. PACS
OverviewMetricsPricesRevenue & ProfitAssets & LiabilitiesCash FlowMarginsPrice RatiosOthers
MetricSide

Standardized stock fundamentals and valuation metrics. Analyze revenue, EBITDA, free cash flow, and more with interactive charts.

Stock Sectors

  • Technology
  • Healthcare
  • Financials
  • Consumer
  • Industrials
  • Energy
  • Real Estate
  • Materials

Legal & Contact

  • Terms of Service
  • Privacy Policy
  • Contact Us
Not Financial Advice: MetricSide is a data aggregation and visualization tool. Nothing on this website constitutes investment advice, a recommendation, or a solicitation to buy or sell any security. All data is provided for informational and educational purposes only. Past performance is not indicative of future results. Always consult a qualified financial professional before making investment decisions. Data accuracy is not guaranteed — verify critical information against official sources.

© 2026 MetricSide. All rights reserved.

PACS Group (PACS) Stock Fundamentals, Analysis & Risk Signals

Health score, competitive moat, risk signals, and key metrics at a glance.

NYSE•Healthcare•Medical Care Facilities
A
ExcellentMetricSide Score: 86/100
ProfitabilityProfit20/30
GrowthGrowth25/25
Balance SheetBalance25/25
Cash QualityCash16/20
Price & Volume
Market Cap $6.99B

PACS Group, Inc., through its subsidiaries, operates skilled nursing facilities and assisted living facilities in the United States. It also provides senior care and independent living facilities. The company engages in the acquisition, ownership, and leasing of health care-related properties. PACS Group, Inc. was founded in 2013 and is headquartered in Salt Lake City, Utah.

Moat Signals

Competitive analysis based on 9 quarters of fundamental data

Pricing Power

Moderate Moat

Operating margins are positive at ~4.5% on average, but show some variability — pricing power may be sensitive to market conditions.

Competitive Advantage

Moderate Moat

ROE is positive at ~13.9% on average, adequate but below the threshold typically associated with wide moats.

Cash Generation

Moderate Moat

7 of the last 8 quarters generated positive FCF. The company generally funds itself but has occasional cash consumption quarters.

Demand Durability

Weak Moat

Revenue has been flat or declining over recent quarters, which may indicate eroding demand or competitive pressure.

Risk Signals

Data-driven red flags and warnings across 9 quarters

Some Concerns

Margin Pressure

Healthy

Margins are stable or improving at ~7.0% — no sign of cost or pricing stress.

Earnings Quality

Watch

FCF/Net Income has dropped below 0.7x in 3 quarters — monitor for earnings quality deterioration.

Leverage Risk

Healthy

D/E ratio is 0.2 — conservative capital structure with low financial risk.

Revenue Decline

Healthy

Revenue is stable or growing over recent quarters — demand appears durable.

Cash Burn

Healthy

Free cash flow is consistently positive — the business self-funds without external capital reliance.

Share Dilution

Red Flag

Shares outstanding increased 5.1% — significant dilution, likely from stock compensation or capital raises.

Metrics at a Glance

as of March 2026

Revenue & Profit

Revenue, EBITDA, operating income, net income, EPS, and shares

TTM Revenue
$5.43B
22.6%
Q. Revenue
$1.42B
TTM EBITDA
$442.52M
223.3%
TTM Op. Income
$381.49M
318.1%
Q. Op. Income
$120.03M
TTM Net Income
$243.77M
594.6%
Q. Net Income
$80.69M
EPS
$0.51
Shares Out.
$157.07M
1.2%
$5.43B in TTM revenue grew 22.6% YoY, reaching $1.42B last quarter. TTM EBITDA of $442.52M and TTM operating income of $381.49M shows growth is flowing through. Net income of $243.77M TTM confirms the company is converting revenue into profit. Revenue is growing at a healthy pace — a signal to hold.

Margins

Gross, EBITDA, operating, and net margin trends

Gross Margin
24.4%
22.8%
EBITDA Margin
9.7%
Op. Margin
8.5%
124.2%
Net Margin
5.7%
154.8%
Op. margin of 8.5% is up 4.7% YoY — cost efficiency is improving. Net margin at 5.7% and gross margin of 24.4% — earnings take a bigger bite when COGS stays lean..

Price Ratios

P/E, P/S, P/B, EV/EBITDA, FCF yield, and earnings yield

P/E Ratio
28.7x
P/S Ratio
1.3x
P/B Ratio
6.7x
At 28.7x P/E, the stock trades in line with market averages — fairly valued. P/S of 1.3x and P/B of 6.7x provide additional context. Assess whether the current multiple is justified by the company's growth and profitability trajectory.

Assets & Liabilities

Total assets, cash, debt, book value, and leverage

Total Assets
$5.66B
Cash
$247.98M
Long-Term Debt
$239.81M
Book Value
$1.04B
D/E Ratio
0.2
Debt/EBITDA
1.7
With $5.66B in assets and $239.81M in long-term debt, the D/E of 0.2and book value of $1.04B — shows a conservative capital structure — the company has a strong financial cushion to weather downturns.

Cash Flow

Operating cash flow, free cash flow, FCF margin, and earnings quality

Op. Cash Flow
$236.34M
Free Cash Flow
$214.51M
61.9%
FCF Margin
3.9%
FCF / Net Income
2.7
FCF of $214.51M on $236.34M in operating cash flow. The FCF / Net Income ratio of 0.9x means earnings are well backed by actual cash — high-quality earnings.

Related Stocks in Healthcare

View Sector
NVDA$4.57T
Nvidia
Semiconductors
GOOG$3.96T
Alphabet Inc. (Class C)
Internet Content & Information
AAPL$3.67T
Apple Inc.
Consumer Electronics
GOOGL$3.66T
Alphabet Inc. (Class A)
Internet Content & Information
MSFT$3.46T
Microsoft
Software - Infrastructure
AMZN$2.56T
Amazon
Internet Retail
META$1.66T
Meta Platforms
Internet Content & Information
AVGO$1.63T
Broadcom
Semiconductors